|
|
中医药研究论丛
 222.7 探讨中医会诊在癌症化疗後的利用率与处方用药－回溯性观察研究
|
TJ TCM.22(2) : 63-70, 2019
|
|
探讨中医会诊在癌症化疗後的利用率与处方用药－回溯性观察研究
Exploring the Utilization and Prescription of TCM Consultation for Post-Chemotherapy Care-A Hospital-Based Retrospective Observational Study
|
|
庄筱梅1 许航甄2 蔡嘉一3 陈威杰1*
1 台南市立安南医院委托中国医药大学兴建经营中医部，台南，台湾
2 台中中山医学大学附设医院中西整合医疗科，台中，台湾
3 台中荣民总医院传统医学科，台中，台湾
|
|
【摘要】
|
|
癌症造成人类生命威胁和高死亡率，世界卫生组织统计，癌症造成全球死亡第二大原因，2015 年全球因癌症死亡880 万人。在台湾癌症已蝉联台湾十大死因之首，许多人在癌症治疗之外（化疗、放疗、标靶），寻求中医辅助治疗，中医会诊可以提供病患第一时间协同中医治疗的照护方式，缓解化疗、放疗、标靶副作用或加强效果。本研究搜寻2013-2017 五年内在某中部医学中心中医会诊的资料，共有3115 人次，因癌症化疗後寻求中医会诊555 (17.81%) 人次，出院一个月内再回诊率高达7 成7，癌症种类依序卵巢癌(28.47%)、肺癌(17.48%)、大肠癌(10.09%)，最常使用中药依序白术、黄芩、牡丹皮、厚朴、炮附子。本研究了解到化疗族群会诊中医利用率明显较其他族群要高，未来希望藉由这次计画结果进行临床试验，来评估中医在癌症化疗後的辅助效果。
|
|
【关键词】中医会诊、化疗、辅助治疗、利用率
|
|
Hsiao-Mei Chuang1 Hang-Chen Hsu2 Chia-I Tsai3 Wei-Chieh Chen1*
1Department of Chinese Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan
2Department of Integrated Chinese and Western Medicine, Chung Shan Medical University,
Hospital, Taichung, Taiwan
3Department of Traditional Chinese Medicine, Taichung Veterans General Hospital, Taichung
40705, Taiwan
|
|
【Summary】
|
|
Cancer poses a serious threat to human well-beings and lead to significant mortality. According to the World Health Organization statistics, cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. In Taiwan, cancer is always the most common cause of death. People suffering from cancer turn to traditional Chinese medicine as combined treatment along with chemotherapy, radiotherapy and target therapy. TCM consultation provides hospitalized patients with an efficient access to collaborative care of traditional Chinese medical treatment as combined treatment to relieve side effects after chemotherapy, radiotherapy, target therapy or enhance the efficacy of current treatment.
We built the study population with the data of TCM consultation in a medical center in central Taiwan during 2013 to 2017. The total utilization of TCM consultation during the five years was 3115 person-times. Among the 3115 person-times, the utilization of TCM consultation for post-chemotherapy was 555 (17.81%), which accounted for the largest proportion. The return rate of chemotherapy population within one month was up to 77.70%. The most common cancer types of TCM consultation for post-chemotherapy care was listed as sequence as ovarian cancer (28.47%), lung cancer (17.48%) and colorectal cancer (10.09%). The most frequently used single herbs was Baizhu (Atractylodes Macrocephala), followed by Huangqin (Scutellaria baicalensis) and Moutan cortex (Paeoniasuffruticosa Andrews).
Through this study, the utilization of TCM consultation for chemotherapy population was higher than non- chemotherapy population. In the near future, we hope to design a randomized, double-blinded, and placebo-controlled clinical trial based on the results of this study to evaluate the efficacy of TCM treatment as a role of collaborative post-chemotherapy care.
|
|
【Keywords】Traditional Chinese medicine consultation, chemotherapy, adjuvant therapy, utilization
|
  |
|
|
